Search Results - Boehnlein, Marion

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised, double-blind, placebo-controlled, adaptive phase III MycarinG study

    Efficacy and safety of rozanolixizumab in patients with muscle-specific tyrosine kinase autoantibody-positive generalised myasthenia gravis: a subgroup analysis of the randomised,... by Habib, Ali A, Sacconi, Sabrina, Antonini, Giovanni, Cortés-Vicente, Elena, Grosskreutz, Julian, Mahuwala, Zabeen K, Mantegazza, Renato, Pascuzzi, Robert M, Utsugisawa, Kimiaki, Vissing, John, Vu, Tuan, Wiendl, Heinz, Boehnlein, Marion, Greve, Bernhard, Woltering, Franz, Bril, Vera

    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  2. 2
    14998 Reductions in absolute PASI over 144 weeks of treatment with certolizumab pegol in patients with plaque psoriasis: Pooled analysis from two phase 3 trials (CIMPASI-1 and CIMPASI-2)

    14998 Reductions in absolute PASI over 144 weeks of treatment with certolizumab pegol in patients with plaque psoriasis: Pooled analysis from two phase 3 trials (CIMPASI-1 and CIMP... by Gottlieb, Alice, Blauvelt, Andrew, Thaci, Diamant, Poulin, Yves, Brock, Fiona, Arendt, Catherine, Boehnlein, Marion, Reich, Kristian

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies

    Rozanolixizumab responder and minimal symptom expression rates in generalized myasthenia gravis: Pooled phase 3 and extension studies by Bril, Vera, Vissing, John, Drużdż, Artur, Grosskreutz, Julian, Habib, Ali A., Mantegazza, Renato, Sacconi, Sabrina, Utsugisawa, Kimiaki, Vu, Tuan, Boehnlein, Marion, Greve, Bernhard, Woltering, Franz, Gayfieva, Maryam

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    15001 Durable efficacy of certolizumab pegol dosed at 400 mg every two weeks over 128 weeks in patients with plaque psoriasis enrolled in three phase 3 trials (CIMPASI-1, CIMPASI-2, and CIMPACT)

    15001 Durable efficacy of certolizumab pegol dosed at 400 mg every two weeks over 128 weeks in patients with plaque psoriasis enrolled in three phase 3 trials (CIMPASI-1, CIMPASI-2... by Gordon, Ken, Warren, Richard B., Gottlieb, Alice B., Blauvelt, Andrew, Thaci, Diamant, Poulin, Yves, Boehnlein, Marion, Brock, Fiona, Arendt, Catherine, Reich, Kristian

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results from a randomised, double-blind, placebo-controlled phase 3 study

    Efficacy and safety of certolizumab pegol in combination with methotrexate in methotrexate-inadequate responder Chinese patients with active rheumatoid arthritis: 24-week results f... by Bi, Liqi, Li, Yuhui, He, Lan, Xu, Huji, Jiang, Zhenyu, Wang, Yongfu, Li, Xiangpei, Wei, Wei, Gu, Jieruo, Wang, Guochun, Zhang, Zhiyi, Zhou, Bin, Liu, Yi, Wu, Zhenbiao, Liu, Huaxiang, He, Dongyi, Lv, Zhaoping, Li, Zhijun, Zuo, Xiaoxia, Dong, Lingli, Wu, Huaxiang, Zhang, Hao, Chen, Haiying, Bao, Chunde, Zhang, Zhuoli, Zhang, Miaojia, Song, Hui, Zheng, Yi, Jiang, Lindi, Liu, Xiangyuan, Boehnlein, Marion, Dunkel, Jochen, Shao, Jing, Harris, Kristina, Li, Zhanguo

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    2634 Cyclical rozanolixizumab treatment in generalised myasthenia gravis (gMG): pooled analysis of MycarinG (Phase 3 study) and two open-label extension studies

    2634 Cyclical rozanolixizumab treatment in generalised myasthenia gravis (gMG): pooled analysis of MycarinG (Phase 3 study) and two open-label extension studies by Welton, Jeremy M, Bril, Vera, Dru d, Artur, Grosskreutz, Julian, Habib, Ali A, Mantegazza, Renato, Utsugisawa, Kimiaki, Vissing, John, Vu, Tuan, Boehnlein, Marion, Gayfieva, Maryam, Greve, Bernhard, Woltering, Franz, Kaminski, Henry J

    Published in BMJ neurology open
    Request full text
    Article
    Save to List
    Saved in:

Search Tools: